Nanhua Bio Medicine Co Ltd Cash Flow Conversion Efficiency
Nanhua Bio Medicine Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Nanhua Bio Medicine Co Ltd (000504) has a cash flow conversion efficiency ratio of 0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥22.42 Million ≈ $3.28 Million USD) by net assets (CN¥362.66 Million ≈ $53.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Nanhua Bio Medicine Co Ltd (1998–2025)
Cash flow conversion efficiency of Nanhua Bio Medicine Co Ltd from 1998 to 2025. This chart illustrates how Nanhua Bio Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Nanhua Bio Medicine Co Ltd stock price today for real-time trading data and today's change.
Nanhua Bio Medicine Co Ltd Cash Flow Conversion Ratio Explained
Nanhua Bio Medicine Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Nanhua Bio Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nanhua Bio Medicine Co Ltd ranked by their cash flow conversion efficiency. Also see 000504 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SNT Motiv Co Ltd
KO:064960
|
0.028x |
|
Hailun Piano Co Ltd
SHE:300329
|
0.006x |
|
SSE PLC
LSE:SSE
|
0.164x |
|
Keystone Technology Co Ltd
SHG:605588
|
0.055x |
|
Skymoons Technology Inc.
KQ:033790
|
0.060x |
|
Shihlin Paper Corp
TW:1903
|
-0.002x |
|
Nanning Department Store Co Ltd
SHG:600712
|
0.000x |
|
Clearfield Inc
NASDAQ:CLFD
|
0.040x |
Annual Cash Flow Conversion Efficiency for Nanhua Bio Medicine Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Nanhua Bio Medicine Co Ltd from 1998 to 2025. Review Nanhua Bio Medicine Co Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥357.51 Million ≈ $52.31 Million |
CN¥-115.74 Million ≈ $-16.94 Million |
-0.324x | -2004.44% |
| 2024-12-31 | CN¥282.00 Million ≈ $41.27 Million |
CN¥4.79 Million ≈ $701.45K |
0.017x | -85.72% |
| 2023-12-31 | CN¥304.67 Million ≈ $44.58 Million |
CN¥36.28 Million ≈ $5.31 Million |
0.119x | -94.28% |
| 2022-12-31 | CN¥79.88 Million ≈ $11.69 Million |
CN¥166.38 Million ≈ $24.35 Million |
2.083x | +114.54% |
| 2021-12-31 | CN¥110.32 Million ≈ $16.14 Million |
CN¥107.10 Million ≈ $15.67 Million |
0.971x | +163.00% |
| 2020-12-31 | CN¥134.48 Million ≈ $19.68 Million |
CN¥-207.22 Million ≈ $-30.32 Million |
-1.541x | -1314.43% |
| 2019-12-31 | CN¥114.46 Million ≈ $16.75 Million |
CN¥14.52 Million ≈ $2.13 Million |
0.127x | +190.02% |
| 2018-12-31 | CN¥107.75 Million ≈ $15.77 Million |
CN¥-15.19 Million ≈ $-2.22 Million |
-0.141x | +61.81% |
| 2017-12-31 | CN¥128.43 Million ≈ $18.79 Million |
CN¥-47.40 Million ≈ $-6.94 Million |
-0.369x | -101.57% |
| 2016-12-31 | CN¥79.76 Million ≈ $11.67 Million |
CN¥-14.60 Million ≈ $-2.14 Million |
-0.183x | -115.47% |
| 2015-12-31 | CN¥-14.51 Million ≈ $-2.12 Million |
CN¥-17.17 Million ≈ $-2.51 Million |
1.184x | +125.51% |
| 2014-12-31 | CN¥7.03 Million ≈ $1.03 Million |
CN¥-32.60 Million ≈ $-4.77 Million |
-4.639x | -41.07% |
| 2013-12-31 | CN¥3.57 Million ≈ $522.49K |
CN¥-11.74 Million ≈ $-1.72 Million |
-3.289x | -1699.99% |
| 2012-12-31 | CN¥-20.80 Million ≈ $-3.04 Million |
CN¥-4.28 Million ≈ $-625.68K |
0.206x | +958.05% |
| 2011-12-31 | CN¥130.38 Million ≈ $19.08 Million |
CN¥-3.12 Million ≈ $-457.01K |
-0.024x | +93.96% |
| 2010-12-31 | CN¥161.13 Million ≈ $23.58 Million |
CN¥-63.95 Million ≈ $-9.36 Million |
-0.397x | -195.00% |
| 2009-12-31 | CN¥144.30 Million ≈ $21.12 Million |
CN¥60.28 Million ≈ $8.82 Million |
0.418x | +725.04% |
| 2008-12-31 | CN¥278.16 Million ≈ $40.70 Million |
CN¥-18.59 Million ≈ $-2.72 Million |
-0.067x | -425.61% |
| 2007-12-31 | CN¥449.00 Million ≈ $65.70 Million |
CN¥9.22 Million ≈ $1.35 Million |
0.021x | +1169.29% |
| 2006-12-31 | CN¥443.78 Million ≈ $64.94 Million |
CN¥717.62K ≈ $105.01K |
0.002x | -93.67% |
| 2005-12-31 | CN¥445.86 Million ≈ $65.24 Million |
CN¥11.40 Million ≈ $1.67 Million |
0.026x | -14.73% |
| 2004-12-31 | CN¥443.86 Million ≈ $64.95 Million |
CN¥13.31 Million ≈ $1.95 Million |
0.030x | -77.23% |
| 2003-12-31 | CN¥423.50 Million ≈ $61.97 Million |
CN¥55.75 Million ≈ $8.16 Million |
0.132x | +221.97% |
| 2002-12-31 | CN¥387.30 Million ≈ $56.67 Million |
CN¥15.83 Million ≈ $2.32 Million |
0.041x | -61.50% |
| 2001-12-31 | CN¥322.29 Million ≈ $47.16 Million |
CN¥34.22 Million ≈ $5.01 Million |
0.106x | +1318.35% |
| 2000-12-31 | CN¥385.75 Million ≈ $56.45 Million |
CN¥-3.36 Million ≈ $-491.98K |
-0.009x | +21.76% |
| 1999-12-31 | CN¥173.52 Million ≈ $25.39 Million |
CN¥-1.93 Million ≈ $-282.86K |
-0.011x | -218.50% |
| 1998-12-31 | CN¥352.69 Million ≈ $51.61 Million |
CN¥3.32 Million ≈ $485.17K |
0.009x | -- |
About Nanhua Bio Medicine Co Ltd
Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. It operates in two segments, Biomedicine, and Energy Saving and Environmental Protection. The Biomedicine segment provides stem cell and immune cell testing, storage, and technical services; as well as sales of biopharmaceutical products, such as beauty products, health supplements, and air purifiers. The Energy Saving and… Read more